Cognitive Effects of Treatment of Interictal Discharges.

Trial Profile

Cognitive Effects of Treatment of Interictal Discharges.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Lamotrigine (Primary) ; Levetiracetam (Primary)
  • Indications Generalised seizures; Partial epilepsies
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Dec 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Planned end date changed from 1 Jan 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 23 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top